Comparison of the performance of HbA1c and fasting plasma glucose in identifying dysglycaemic status in Chinese high-risk subjects

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 2, 2013, Pages 63-68

  Du, Ting Ting ^a   Yin, Ping ^a   Zhang, Jian Hua ^a   Zhang, Dan ^a   Shi, Wei ^a   Yu, Xue Feng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Diabetes; Diagnosis; HbA1c

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CHINESE; COMPARATIVE STUDY; DIABETES MELLITUS; DYSGLYCEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; RISK FACTORS;

EID: 84873139868     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12038     Document Type: Article

References (26)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl. 1): S62-9.
2. Zhou X, Pang Z, Gao W et al. Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China. Diabetes Care 2010; 33: 545-50.
3. Zhou XH, Ji LN, Luo YY, Zhang XY, Han XY, Qiao Q. Performance of HbA(1c) for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing. Diabet. Med. 2009; 26: 1262-8.
4. Bao Y, Ma X, Li H et al. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: Cross sectional epidemiological survey. BMJ 2010; 340: c2249.
5. Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P. Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 2010; 33: 2190-5.
6. Lipska KJ, De Rekeneire N, Van Ness PH et al. Identifying dysglycemic states in older adults: Implications of the emerging use of hemoglobin A1c. J. Clin. Endocrinol. Metab. 2010; 95: 5289-95.
7. Costa B, Barrio F, Cabre JJ et al. Shifting from glucose diagnostic criteria to the new HbA(1c) criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population. Diabet. Med. 2011; 28: 1234-7.
8. Kim CH, Kim HK, Bae SJ, Park JY, Lee KU. Discordance between fasting glucose-based and hemoglobin A1c-based diagnosis of diabetes mellitus in Koreans. Diabetes Res. Clin. Pract. 2011; 91: e8-10.
9. Kramer CK, Araneta MR, Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care 2010; 33: 101-3.
10. Heianza Y, Hara S, Arase Y et al. HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): A longitudinal cohort study. Lancet 2011; 378: 147-55.
11. Carson AP, Reynolds K, Fonseca VA, Muntner P. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010; 33: 95-7.
12. Trevino G. Consensus statement on the Worldwide Standardization of the Hemoglobin A1C Measurement: The American Diabetes Association, European Association For the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation: Response to the Consensus Committee. Diabetes Care 2007; 30: e141.
13. Selvin E, Steffes MW, Zhu H et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N. Engl. J. Med. 2010; 362: 800-11.
14. Yang W, Lu J, Weng J et al. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 2010; 362: 1090-101.
15. Pani LN, Korenda L, Meigs JB et al. Effect of aging on A1C levels in individuals without diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008; 31: 1991-6.
16. Qiao Q, Nakagami T, Tuomilehto J et al. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000; 43: 1470-5.
17. Nathan DM, Davidson MB, DeFronzo RA et al. Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care 2007; 30: 753-9.
18. Goldstein DE, Little RR, Lorenz RA et al. Tests of glycemia in diabetes. Diabetes Care 2004; 27: 1761-73.
19. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: Results from the Veterans Administration Genetic Epidemiology Study. Diabetes 2006; 55: 1430-5.
20. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Variations with increasing levels of HbA(1c). Diabetes Care 2003; 26: 881-5.
21. Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007; 30: 263-9.
22. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002; 346: 393-403.
23. Lorenzo C, Wagenknecht LE, Hanley AJ, Rewers MJ, Karter AJ, Haffner SM. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: The Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010; 33: 2104-9.
24. Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 2010; 33: 2184-9.
25. Mostafa SA, Khunti K, Srinivasan BT, Webb D, Gray LJ, Davies MJ. The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Res. Clin. Pract. 2010; 90: 100-8.
26. Gerstein HC, Santaguida P, Raina P et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Res. Clin. Pract. 2007; 78: 305-12.